CopenHeartVR - Integrated Rehabilitation of Patients After Heart Valve

Status Completed

Clinical Trial Summary

The aim of the study is to investigate the effect of an integrated rehabilitation programme, consisting of physical exercise training and psycho-educational consultations, for patients after heart valve surgery.

The hypothesis is that integrated rehabilitation can improve physical capacity measured by V02 peak, self-rated mental health and life quality by validated questionnaires such as SF-36, and other objective parameters such as cardiac-specific biomarkers and echocardiographic measurements.

Clinical Trial Description

Worldwide, the incidence of heart valve disease is increasing. Improved surgical techniques, rising age and possibility for re-operation leads to a rising number of patients having heart valve surgery. The gap between hospital discharge and returning to normal life is obvious. Integrated rehabilitation could probably reduce hospital readmissions, increase physical capacity and increase self-rated mental health and quality of life. Therefore the aim of this study is to explore if patients after heart valve surgery will benefit from an integrated rehabilitation programme consisting of physical exercise and psycho-educational intervention.

A randomized clinical trial is conducted to investigate the effect and meaning of an integrated rehabilitation programme on the physical and psychosocial functioning of patients after heart valve surgery. The trial is a parallel arm design.

A mixed methods embedded experimental design is chosen to include both quantitative and qualitative data to evaluate the intervention. The intervention consists of five psycho-educational consultations provided by specialized nurses and a twelve week individualized exercise training programme provided by physiotherapists. A qualitative post-intervention study will explore rehabilitation participation experiences.

Along with the above stated hypothesis, it will be observed whether integrated rehabilitation can reduce anxiety, depression, health care utilisation, mortality and work cessation.

210 patients will be included.

Validated questionnaires (e.g. SF-36), cardiopulmonary exercise testing, 6 minute walking test, echocardiography, cardiac-specific biomarkers and qualitative interviews will be used to evaluate the effect and meaning of the programme. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01558765
Study type	Interventional
Source	Rigshospitalet, Denmark
Contact
Status	Completed
Phase	Phase 2
Start date	March 2012
Completion date	May 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06027788` - CTSN Embolic Protection Trial	N/A
Completed	`NCT02527629` - Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")
Completed	`NCT01178710` - Effect of Simvastatin on Cardiac Function	N/A
Completed	`NCT01426776` - Effect of Heart Valve Replacement on Cheyne-Stokes Respiration	N/A
Completed	`NCT00581399` - A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery	Phase 2
Withdrawn	`NCT00187304` - ACTION - Anticoagulation Treatment Influence on Post-operative Patients	Phase 4
Terminated	`NCT00700947` - Using Beta Blockers to Treat Mitral Regurgitation	Phase 1
Recruiting	`NCT02650388` - Frailty and Cognitive Function Assessment of TAVI Patients	Phase 4
Recruiting	`NCT02574650` - Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.	N/A
Completed	`NCT01996657` - D-dimer and Oral Anticoagulation Therapy in Patients With Mechanical Valve Replacement	N/A
Terminated	`NCT00598936` - A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients	Phase 1
Terminated	`NCT01812174` - On-X Heart Valve - 17mm Aortic and 23mm Mitral	N/A
Recruiting	`NCT03225612` - Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)	N/A
Completed	`NCT01384643` - Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery	Phase 4
Active, not recruiting	`NCT00291525` - Randomized On-X Anticoagulation Trial	N/A
Completed	`NCT02867930` - Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography	Phase 4
Recruiting	`NCT02478008` - A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)	N/A
Completed	`NCT02790008` - Magnetic Resonance Imaging and Fibrosis
Completed	`NCT02587039` - An Intervention to Reduce Delirium After Cardiac Surgery	N/A
Recruiting	`NCT01855737` - The Study of Warfarin Maintenance Dose in Chinese Patients	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

CopenHeartVR - Integrated Rehabilitation of Patients After Heart Valve Surgery — CopenHeartVR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms